Immunomedics Stock Price, News & Analysis

IMMU NASDAQ

Company Description

Immunomedics (NASDAQ: IMMU) is a publicly traded biotechnology company in the Health Technology sector.

IMMU stock has gained 446.1% over the past year.

This page provides a comprehensive overview of IMMU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+446.05%

Performance 1 year

$0.0

Market Cap

231.2M

Shares outstanding

Immunomedics (IMMU) stock. Over the past 12 months, the stock has gained 446.1%.

Latest News

View All

October 12, 2020

+0.12%

Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma

clinical trial fda approval

September 19, 2020

-0.14%

Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer

clinical trial

September 19, 2020

-0.14%

Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer

clinical trial

September 18, 2020

+0.22%

Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers

clinical trial

September 9, 2020

+4.27%

Immunomedics Announces Key Oral Presentations at ESMO Virtual Congress 2020

September 2, 2020

-2.47%

Immunomedics to Participate in Upcoming Healthcare Conferences

conferences

Immunomedics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, fda approval, conferences, earnings. View all IMMU news →

SEC Filings

View All

No SEC filings available for IMMU.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IMMU Company Profile & Sector Positioning

Immunomedics (IMMU) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.